| 英文名称 |
中文名称 |
CAS号 |
操作 |
| BEZ235 |
NVP-BEZ235 |
915019-65-7 |
详细
|
| NVP-TAE684 |
NVP-TAE684 |
761439-42-3 |
详细
|
| AST487 |
AST 487 |
630124-46-8 |
详细
|
| GNE-7915 |
GNE7915 |
1351761-44-8 |
详细
|
| PI-3065 |
PI-3065 |
955977-50-1 |
详细
|
| Entasobulin |
501921-61-5 |
501921-61-5 |
详细
|
| FITM |
4-氟-N-[4-[6-(异丙基氨基)嘧啶-4-基]-1,3-噻唑-2-基]-N-甲基苯甲酰胺 |
932737-65-0 |
详细
|
| FGF-401 |
8-二氮杂萘-1(2H)-甲酰胺 |
1708971-55-4 |
详细
|
| JAK3-IN-6 |
JAK3-IN-6 |
1443235-95-7 |
详细
|
| GRA Ex-25 |
N-[4-[[[反式-4-(1,1-二甲基乙基)环己基][[[4-(三氟甲氧基)苯基]氨基]羰基]氨基]甲基]苄基]-B-丙氨酸 |
307983-31-9 |
详细
|
| BCTC |
N-(4-叔丁苯基)-4-(3-氯吡啶-2-基)哌嗪-1-甲酰胺 |
393514-24-4 |
详细
|
| ISX9 |
ISX 9 |
832115-62-5 |
详细
|
| KHS-101 |
KHS101 |
1262770-73-9 |
详细
|
| CCT241736 |
CS-2683 |
1402709-93-6 |
详细
|
| Liproxstatin-1 |
利普司他丁-1 |
950455-15-9 |
详细
|
| FAUC-365 |
FAUC-365 |
474432-66-1 |
详细
|
| CHZ868 |
1895895-38-1 |
1895895-38-1 |
详细
|
| PF-9366 |
PF-9366 |
72882-78-1 |
详细
|
| Fantofarone |
泛托法隆 |
114432-13-2 |
详细
|
| CAY10594 |
CAY10594 |
1130067-34-3 |
详细
|
| Avitinib (AC0010) |
艾维替尼 |
1557267-42-1 |
详细
|
| GENZ-682452 |
GENZ-682452 |
1401090-53-6 |
详细
|
| BAM 15 |
CS-2890 |
210302-17-3 |
详细
|
| gsk2200150a |
1443138-53-1 |
1443138-53-1 |
详细
|
| PD-1/PD-L1-IN1 |
BMS-1166 |
1818314-88-3 |
详细
|
| Doramapimod (BIRB 796) |
1-[2-(4-甲基苯基)-5-叔丁基吡唑-3-基]-3-[4-(2-吗啉-4-基乙氧基)萘-1-基]脲 |
285983-48-4 |
详细
|
| BMS-309403 |
BMS309403 |
300657-03-8 |
详细
|
| Losmapimod (GW856553X) |
Losmapimod (GW856553X) |
585543-15-3 |
详细
|
| LKB1 (AAK1 dual inhibitor) |
N-[5-(4-氰基苯基)-1H-吡咯并[2,3-B]吡啶-3-基]-3-吡啶甲酰胺 |
1093222-27-5 |
详细
|
| Azoramide |
N-[2-[2-(4-氯苯基)-4-噻唑基]乙基]丁酰胺 |
932986-18-0 |
详细
|
| AZD3463 |
AZD3463 |
1356962-20-3 |
详细
|
| HG-9-91-01 |
N-(2,4-二甲氧基苯基)-N'-(2,6-二甲基苯基)-N-[6-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]脲 |
1456858-58-4 |
详细
|
| GLPG0634 |
GLPG0634 |
1206101-20-3 |
详细
|
| BN-82002 |
396073-89-5 |
396073-89-5 |
详细
|
| LY364947 |
LY 364947 |
396129-53-6 |
详细
|
| Nucleozin |
[4-(2-氯-4-硝基苯基)-1-哌嗪基](5-甲基-3-苯基-4-异噁唑基)-甲酮 |
341001-38-5 |
详细
|
| PF-573228 |
6-[(4-((3-(甲磺酰基)苄基)氨基)-5-三氟甲基嘧啶-2-基)氨基]-3,4-二氢-1H-喹啉-2-酮 |
869288-64-2 |
详细
|
| Mocetinostat(MGCD0103) |
N-(2-氨基苯基)-4-([[4-(吡啶-3-基)嘧啶-2-基]氨基]甲基)苯甲酰胺 |
726169-73-9 |
详细
|
| JNJ-26481585 |
JNJ 26854165 |
875320-29-9 |
详细
|
| CPI-444 |
CPI-444 |
1202402-40-1 |
详细
|
| BLZ945 |
BLZ945 |
953769-46-5 |
详细
|
| IKKε-IN-1 |
CS-1801 |
1292310-49-6 |
详细
|
| ITX5061 |
1252679-52-9 |
1252679-52-9 |
详细
|
| MELK-8a hydrochloride |
MELK-8a |
1922153-17-0 |
详细
|
| Desciclovir |
地昔洛韦 |
84408-37-7 |
详细
|
| OSI-930 |
3-[(4-喹啉甲基)氨基]-N-[4-(三氟甲氧基)苯基]-2-噻吩甲酰胺 |
728033-96-3 |
详细
|
| PF-8380 |
4-[3-氧代-3-(2-氧代-2,3-二氢苯并恶唑-6-基)丙基]哌嗪-1-羧酸 3,5-二氯苄酯 |
1144035-53-9 |
详细
|
| NVP-BGT226 |
NVP-BGT226 |
1245537-68-1 |
详细
|
| AUZ-454 |
K03861 |
853299-07-7 |
详细
|
| GDC0575 hydrochloride |
GDC0575 HYDROCHLORIDE |
1196504-54-7 |
详细
|
| Ro28-2653 |
CS-2736 |
261956-22-3 |
详细
|
| None |
BI-1347 |
2163056-91-3 |
详细
|
| E7820 |
CS-2701 |
289483-69-8 |
详细
|
| LY-293111 |
Etalocib |
161172-51-6 |
详细
|
| NONE |
化合物GATA4-NKX2-5-IN-1 |
544681-96-1 |
详细
|
| HA130 |
HA 130,自分泌运动抑制剂 |
1229652-21-4 |
详细
|
| INCB8761 |
N-[2-[(3S)-3-[[4-羟基-4-[5-(嘧啶-2-基)吡啶-2-基]环己基]氨基]吡咯烷-1-基]-2-氧代乙基]-3-(三氟甲基)苯甲酰胺 |
857679-55-1 |
详细
|
| ALK inhibitor 2 |
2-[[5-氯-2-[[2-甲氧基-4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]-N-甲基苯磺酰胺 |
761438-38-4 |
详细
|
| OT-R antagonist 1 |
化合物 T12331L |
364071-17-0 |
详细
|
| GNF 5837 |
GNF 5837 |
1033769-28-6 |
详细
|
| Ki 8751 |
Ki8751 |
228559-41-9 |
详细
|
| ON 579 |
ON-579 |
141286-14-8 |
详细
|
| PF-562271 |
N-甲基-N-[3-[[[2-[(2-氧代-2,3-二氢-1H-吲哚-5-基)氨基]-5-三氟甲基嘧啶-4-基]氨基]甲基]吡啶-2-基]甲磺酰胺 |
717907-75-0 |
详细
|
| GSK126 |
GSK126 |
1346574-57-9 |
详细
|
| GSK503 |
化合物GSK503 |
1346572-63-1 |
详细
|
| PQR309 |
PI3K/MTOR抑制剂 |
1225037-39-7 |
详细
|
| ARN14974 |
ARN14974 |
1644158-57-5 |
详细
|
| Ezutromid |
依珠曲米 |
945531-77-1 |
详细
|
| 5WKS |
化合物5WKS |
1350752-07-6 |
详细
|
| BP897 |
N-[4-[4-(2-甲氧基苯基)-1-哌嗪基]丁基]-2-萘甲酰胺单盐酸盐 |
314776-92-6 |
详细
|
| Pirmenol |
Pirmenol |
68252-19-7 |
详细
|
| ADL-5859 |
N,N-二乙基-4-(5-羟基螺[2H-1-苯并吡喃-2,4'-哌啶]-4-基)苯甲酰胺盐酸盐 |
850173-95-4 |
详细
|
| AMG-517 |
N-[4-[[6-[4-(三氟甲基)苯基]-4-嘧啶基]氧基]-2-苯并噻唑基]乙酰胺 |
659730-32-2 |
详细
|
| AMG900 |
AMG 900 |
945595-80-2 |
详细
|
| IRAK inhibitor |
环巴胺抑制剂 1 |
1042224-63-4 |
详细
|
| KD025 (SLx-2119) |
2-[3-[4-[(1H-吲唑-5-基)氨基]喹唑啉-2-基]苯氧基]-N-异丙基乙酰胺 |
911417-87-3 |
详细
|
| ALW-II-41-27 |
ALW-II-41-27 |
1186206-79-0 |
详细
|
| GZD824 |
GZD824 |
1257628-77-5 |
详细
|
| ML281 |
ML281 |
1404437-62-2 |
详细
|
| HG-14-10-04 |
CS-1175 |
1356962-34-9 |
详细
|
| PF-3450074 |
PF-3450074 |
1352879-65-2 |
详细
|
| PFI-2 HCl |
1627607-87-7 |
1627607-87-7 |
详细
|
| EAI045 |
EAI-045 |
1942114-09-1 |
详细
|
| NCT-503 |
NCT503 |
1916571-90-8 |
详细
|
| Autophinib |
6-CHLORO-N-(5-METHYL-1H-PYRAZOL-3-YL)-2-(4-NITROPHENOXY)PYRIMIDIN-4-AMINE |
1644443-47-9 |
详细
|
| GSK 2643943A |
GSK2643943A |
|
详细
|
| E-4031 |
N-[4-[[1-[2-(6-甲基-2-吡啶基)乙基]-4-哌啶基]羰基]苯基]甲烷磺酰胺二盐酸盐 |
113559-13-0 |
详细
|
| Pleconaril |
普可那利 |
153168-05-9 |
详细
|
| Bay 59-3074 |
BAY 59-3074 |
406205-74-1 |
详细
|
| MI 2 |
2-氯-N-[4-[5-(3,4-二氯苯基)-3-(2-甲氧基乙氧基)-1H-1,2,4-三唑-1-基]苯基]乙酰胺 |
1047953-91-2 |
详细
|
| AZD-7325 |
3-CinnolinecarboxaMide, 4-aMino-8-(2-fluoro-6-Methoxyphenyl)-N-propyl- |
942437-37-8 |
详细
|
| Lu AE 58054 |
LU AE58054 |
467459-31-0 |
详细
|
| IKK16 |
IKK-16 |
873225-46-8 |
详细
|
| LY2828360 |
CS-2878 |
1231220-79-3 |
详细
|
| NVP-BAW2881 |
BAW2881 |
861875-60-7 |
详细
|
| CEP-40783 |
CEP-40783 |
1437321-24-8 |
详细
|
| JNJ0966 |
JNJ0966 |
315705-75-0 |
详细
|
| NVP-BSK805 dihydrochloride |
1942919-79-0 |
1942919-79-0 |
详细
|
| LY-2940094 |
BTRX-246040 |
1307245-86-8 |
详细
|